Chromosome arm 8p and cancer:: a fragile hypothesis

被引:56
作者
Birnbaum, D
Adélaïde, J
Popovici, C
Charafe-Jauffret, E
Mozziconacci, MJ
Chaffanet, M
机构
[1] U119 INSERM, IFR57, F-13009 Marseille, France
[2] Inst J Paoli I Calmettes, Dept Mol Oncol, Marseille, France
关键词
D O I
10.1016/S1470-2045(03)01225-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chromosome arm 8p is one of the most frequently altered regions in human cancers. Several potential oncogenes and tumour suppressor genes have been identified but further investigations are needed to confirm which are bona fide oncogenic targets. In cancer cells, chromosome breaks may occur at fragile sites throughout the genome. Some fragile sites lie within genes that may have a role in cancer; the best example is FHIT at 3p14, which contains the fragile site FRA3B. We have found that chromosome breaks disrupt the NRG1 gene at 8p12 in breast and pancreatic cancers. We hypothesise that alteration of the NRG1 gene could occur through breakage at a non-common fragile site.
引用
收藏
页码:639 / 642
页数:4
相关论文
共 51 条
[1]   A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRGI gene [J].
Adélaïde, J ;
Huang, HE ;
Murati, A ;
Alsop, AE ;
Orsetti, A ;
Mozziconacci, MJ ;
Popovici, C ;
Ginestier, C ;
Letessier, A ;
Basset, C ;
Courtay-Cahen, C ;
Jacquemier, J ;
Theillet, C ;
Birnbaum, D ;
Edwards, PAW ;
Chaffanet, M .
GENES CHROMOSOMES & CANCER, 2003, 37 (04) :333-345
[2]   THE HEREGULIN GENE CAN BE INCLUDED IN THE 8P12 AMPLIFICATION UNIT IN HUMAN BREAST-CANCER [J].
ADELAIDE, J ;
PENAULTLLORCA, F ;
DIB, A ;
YARDEN, Y ;
JACQUEMIER, J ;
BIRNBAUM, D .
GENES CHROMOSOMES & CANCER, 1994, 11 (01) :66-69
[3]  
Adélaïde J, 2000, INT J ONCOL, V16, P683
[4]   Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells [J].
Aguilar, Z ;
Akita, RW ;
Finn, RS ;
Ramos, BL ;
Pegram, MD ;
Kabbinavar, FF ;
Pietras, RJ ;
Pisacane, P ;
Sliwkowski, MX ;
Slamon, DJ .
ONCOGENE, 1999, 18 (44) :6050-6062
[5]  
Atlas E, 2003, MOL CANCER RES, V1, P165
[6]   Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer [J].
Bärlund, M ;
Monni, O ;
Weaver, JD ;
Kauraniemi, P ;
Sauter, G ;
Heiskanen, M ;
Kallioniemi, OP ;
Kallioniemi, A .
GENES CHROMOSOMES & CANCER, 2002, 35 (04) :311-317
[7]  
Bautista S, 1998, GENE CHROMOSOME CANC, V22, P268, DOI 10.1002/(SICI)1098-2264(199808)22:4<268::AID-GCC2>3.3.CO
[8]  
2-U
[9]  
Bednarek AK, 2000, CANCER RES, V60, P2140
[10]   Tumour-suppressor genes in prostatic oncogenesis: A positional approach [J].
Bookstein, R ;
Bova, GS ;
MacGrogan, D ;
Levy, A ;
Isaacs, WB .
BRITISH JOURNAL OF UROLOGY, 1997, 79 :28-36